< 1 minute read
Sep. 18, 2021

CB-5083: An Inhibitor of p97/Valosin-Containing Protein

CB-5083

p97/VCP ATPase inhibitor (PDE6 off-target) Ph. I in cancer (discont., dyschromatopsia) from HTS of NIH compound library J. Pharmacol. Exp. Ther., Apr. 30, 2021 Cleave Therapeutics, San Francisco, CA

twitterlinkedinprintemail